1. Home
  2. ITRM vs PRME Comparison

ITRM vs PRME Comparison

Compare ITRM & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • PRME
  • Stock Information
  • Founded
  • ITRM 2015
  • PRME 2019
  • Country
  • ITRM Ireland
  • PRME United States
  • Employees
  • ITRM N/A
  • PRME N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • PRME Medicinal Chemicals and Botanical Products
  • Sector
  • ITRM Health Care
  • PRME Health Care
  • Exchange
  • ITRM Nasdaq
  • PRME Nasdaq
  • Market Cap
  • ITRM 40.0M
  • PRME 191.7M
  • IPO Year
  • ITRM 2018
  • PRME 2022
  • Fundamental
  • Price
  • ITRM $0.96
  • PRME $3.14
  • Analyst Decision
  • ITRM Strong Buy
  • PRME Buy
  • Analyst Count
  • ITRM 2
  • PRME 6
  • Target Price
  • ITRM $7.00
  • PRME $9.38
  • AVG Volume (30 Days)
  • ITRM 532.9K
  • PRME 3.7M
  • Earning Date
  • ITRM 08-13-2025
  • PRME 08-04-2025
  • Dividend Yield
  • ITRM N/A
  • PRME N/A
  • EPS Growth
  • ITRM N/A
  • PRME N/A
  • EPS
  • ITRM N/A
  • PRME N/A
  • Revenue
  • ITRM N/A
  • PRME $3,846,000.00
  • Revenue This Year
  • ITRM N/A
  • PRME $104.12
  • Revenue Next Year
  • ITRM $270.19
  • PRME $196.78
  • P/E Ratio
  • ITRM N/A
  • PRME N/A
  • Revenue Growth
  • ITRM N/A
  • PRME 550.76
  • 52 Week Low
  • ITRM $0.81
  • PRME $1.11
  • 52 Week High
  • ITRM $3.02
  • PRME $6.75
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 44.42
  • PRME 79.25
  • Support Level
  • ITRM $0.93
  • PRME $2.28
  • Resistance Level
  • ITRM $1.03
  • PRME $2.78
  • Average True Range (ATR)
  • ITRM 0.04
  • PRME 0.34
  • MACD
  • ITRM -0.00
  • PRME 0.12
  • Stochastic Oscillator
  • ITRM 26.15
  • PRME 81.62

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Share on Social Networks: